It is well known that inherited and acquired changes in pre-mRNA splicing play a significant role in human disease development and many cancer-associated genes are regulated by alternative splicing, such as CD44, the Wilms' tumor gene WT1, BRCA1, MDM2, FGFR and kallikrein family members [56, 57]. The gene discussed is BRCA1; the disease is cancer.